Vectura Group (VEC)

Sector: Pharma and Biotech     Index: FTSE 250
-1.09%
-1.70p
154.10p
17:17 30/03/17
154.10p
17:17 30/03/17
DAILY VARIATION
-1.09%
-1.70p
VOLUME
2,744,808
REAL TIME BATS
153.80p
17:36 30/03/17
-1.47%
-2.30p
DATA
52 Week High
177.30p
52 Week Low
126.80p
Shares Issued
677.98m
Market Cap
£1,044.76m
RiskGrade
133
Beta
0.98
MENU

Vectura Group Overview

Vectura develops inhaled therapies principally for the treatment of respiratory diseases.

Intraday Chart

Historic Charts

Latest F'cast
Div Yield 0.0% 0.0%
Div Cover n/a n/a
Op Mrgn -35.2% 24.4%
ROCE 0.0%
Latest F'cast
P/E 21.0 22.4
PEG 0.7 -7.4
Pr/Revenue 6.3 5.3
Pr/Book 1.6
Latest F'cast
Revenue 133.2% 96.9%
PBT 0.0% n/a
EPS 30.4% 12.0%
DPS n/a 0.0%

Key Fundamentals

slide to see more
Year Ending Revenue (£m) Pre-tax (£m) EPS P/E PEG EPS Grth. Div Yield
2012-03-31 33.00 -13.20 -1.30p -41.7 0.0 n/a n/a 0.0%
2013-03-31 30.50 -10.40 -1.80p -50.4 0.0 n/a n/a 0.0%
2014-03-31 36.50 -4.80 1.50p 102.2 0.0 n/a n/a 0.0%
2015-03-31 58.00 -6.20 4.00p 36.4 0.2 167% n/a 0.0%
2016-03-31 72.00 -1.90 5.70p 28.5 0.7 42% n/a 0.0%
2016-12-31 126.50 -40.10 7.43p 18.4 0.6 30% n/a 0.0%

Forecast

slide to see more
Year Ending Revenue (£m) Pre-tax (£m) EPS P/E PEG EPS Grth. Div Yield
2017-12-31 198.51 48.40 7.22p 22.4 -7.7 -3% 0.00p 0.0%
2018-12-31 250.98 87.37 11.25p 12.5 0.2 56% 0.00p 0.0%

Regulatory News

slide to see more
Vectura Group Preliminary Results 21-Mar-17 07:05
Director/PDMR Share Dealing 09-Mar-17 09:00
Board Change 06-Mar-17 12:49

Newspaper Links

No results found